Richard Moriggl
Impact in
- Immunology top 0.5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 0.5%
- Cytokine Signaling Pathways and Interactions
Papers in
- Oncology 100
- Cytokine Signaling Pathways and Interactions 82
- Immunology 65
- Immune Cell Function and Interaction 21
- T-cell and B-cell Immunology 13
Richard Moriggl
168 papers receiving 10.1k citations
Peers
Comparison fields: 5 of 132
- Immunology 3.5k
- Oncology 4.4k
- Hematology 1.6k
- Genetics 1.3k
- Cancer Research 1.4k
Countries citing papers authored by Richard Moriggl
This map shows the geographic impact of Richard Moriggl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Moriggl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Moriggl more than expected).
Fields of papers citing papers by Richard Moriggl
This network shows the impact of papers produced by Richard Moriggl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Moriggl. The network helps show where Richard Moriggl may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard Moriggl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 10 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 62 | |
| 7 | 2021 | 4 | |
| 8 | 2021 | 6 | |
| 9 | 2021 | 29 | |
| 10 | 2020 | 214 | |
| 11 | 2018 | 4 | |
| 12 | 2017 | 24 | |
| 13 | 2016 | 123 | |
| 14 | 2009 | 170 | |
| 15 | 2009 | 57 | |
| 16 | 2009 | 60 | |
| 17 | 2008 | 58 | |
| 18 | 2007 | 471 | |
| 19 | 2006 | 168 | |
| 20 | 1996 | 247 |
About Richard Moriggl
Richard Moriggl is a scholar working on Oncology, Immunology, Hematology, Genetics and Cancer Research, having authored 176 papers that have together received 10.2k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (82 papers), Chronic Myeloid Leukemia Treatments (24 papers), Immune Cell Function and Interaction (21 papers), NF-κB Signaling Pathways (18 papers), Chronic Lymphocytic Leukemia Research (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers), T-cell and B-cell Immunology (13 papers) and Acute Myeloid Leukemia Research (12 papers). The work is most often cited by research in Immunology (3.5k citations), Oncology (4.4k citations), Hematology (1.6k citations), Genetics (1.3k citations) and Cancer Research (1.4k citations). Richard Moriggl has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Veronika Sexl, James N. Ihle, Hartmut Beug, Kevin D. Bunting, Peter Valent, Lothar Hennighausen, Bernd Groner, Karlheinz Friedrich, Lukas Kenner and Marc A. Kerenyi. Their work appears in journals such as Blood, Cancers, Oncotarget, Oncogene and Cytokine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.